A Tolerance Trial of Cinobufacini Injection Intraperitoneal Perfusion on Digestive System Cancer With Ascites

NCT02530398 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Digestive System Cancer
Malignant Ascites

Interventions

DRUG: Cinobufacini Injection

Sponsor

Dongfang Hospital Beijing University of Chinese Medicine